Air Products and Chemicals, Inc vs Freeport-McMoRan, Inc. — Stock Comparison
Q·Score Breakdown
5.7
Hold
Overall
8.4
Buy
Quality
Health
Growth
Valuation
Sentiment
APD
Positive growth trajectory.
⚠ currently unprofitable (-3% margin).
FCX
Clean balance sheet with low leverage (0.3× debt-to-equity).
Analyst Consensus
BUY
Target $317.57 (+5.8%)
21 analysts
BUY
Target $67.90 (+18.1%)
21 analysts
Fundamentals
APD
FCX
—
Trailing P/E
30.4×
21.2×
Forward P/E
15.5×
-2.7%
Profit Margin
10.3%
31.6%
Gross Margin
37.1%
-1.7%
ROE
15.6%
5.8%
Revenue Growth
8.8%
9.7%
Earnings Growth
154.0%
0.81
Beta
1.47
—
Price / Book
—
$66.8B
Market Cap
$82.5B
$229 – $307
52-Week Range
$35 – $71
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.